
    
      A Phase 1, Open Label, Two-cohort, Non-randomized Fixed Sequence Study To Evaluate The
      Pharmacokinetic Drug Drug Interaction Between Pf-05221304 And Pf-06865571 In Healthy Adult
      Subjects
    
  